Skip to main content

Closed

IMRN: Immuron Limited Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+48.6% / yr

Operating margin-68.4%

ROIC-29.0%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-518.1×

Current ratio8.04×

Immuron Limited

IMRNNASDAQ Capital Market·USD·Closed

Immuron Limited

IMRNNASDAQ·USD·Closed

$1.09

−1.80%

$1.09

−$0.02 (1.80%)

52W Range

24thpctl

Volume

0.05×avg

Mkt Cap

7.03MUSD

P/E

-1.9TTM

Div Yield

–ann

52W Range

24thpctl

Volume

0.05×avg

Market Cap

7.03MUSD

P/E Ratio

-1.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings